US FDA tightens regulations for use of erythopoiesis-stimulating agents

被引：0

|

作者：

不详

机构：

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2010年 / 10卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：483 / 483

页数：1

相关论文

共 50 条

[1] US FDA tightens regulations for use of erythopoiesis-stimulating agents
不详
[J]. EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (02) : 128 - 128
[2] Persistent anaemia after allogeneic stem cell transplantation is associated with inadequate erythropoietin (Epo) secretion and easily reverts with erythopoiesis-stimulating proteins
Gaya, A
Urbano-Ispizua, A
Fernández-Avilés, F
Mendizábal, M
Martínez, C
Rovira, M
Talarn, C
Granell, M
Carreras, E
Montserrat, E
[J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S183 - S183
[3] HAVE FDA HEARING REGULATIONS FAILED US
PENDERGAST, WR
[J]. FOOD DRUG COSMETIC LAW JOURNAL, 1968, 23 (11): : 524 - 531
[4] US regulations FDA moves to avert drug shortages
O'Driscoll, Cath
[J]. CHEMISTRY & INDUSTRY, 2013, 77 (12) : 7 - 7
[5] Gadolinium-based contrast agents safe to use, says US FDA
[J]. Reactions Weekly, 2017, 1654 (1) : 1 - 1
[6] ANTINEOPLASTIC AGENTS AND FDA REGULATIONS - SQUARE PEGS FOR ROUND HOLES
WITTES, RE
[J]. CANCER TREATMENT REPORTS, 1987, 71 (09): : 795 - 806
[7] US companies challenge new FDA regulations on tobacco advertising
Tanne, Janice Hopkins
[J]. BRITISH MEDICAL JOURNAL, 2009, 339
[8] FDA restricts use of erythropoiesis stimulating drugs
Tanne, Janice Hopkins
[J]. BRITISH MEDICAL JOURNAL, 2010, 340
[9] Use of erythropoiesis stimulating agents
Lapierre, A.
Souquet, P. -J.
[J]. REVUE DES MALADIES RESPIRATOIRES, 2014, 31 (02) : 162 - 172
[10] The New Label for Erythropoiesis Stimulating Agents: The FDA'S Sentence
Fishbane, Steven
Jhaveri, Kenar D.
[J]. SEMINARS IN DIALYSIS, 2012, 25 (03) : 263 - 266

← 1 2 3 4 5 →